3309 — C-Mer Medical Holdings Balance Sheet
0.000.00%
- HK$1.59bn
- HK$1.71bn
- HK$1.95bn
Annual balance sheet for C-Mer Medical Holdings, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | ARS | ARS | ARS | ARS | PRESS |
| Standards: | IFRS | IFRS | IFRS | IFRS | — |
| Status: | Final | Final | Final | Final | Final |
| Cash | |||||
| Cash and Equivalents | |||||
| Short Term Investments | |||||
| Cash and Short Term Investments | 442 | 699 | 557 | 467 | 466 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 30.1 | 53.9 | 66.7 | 74.5 | 67.9 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 746 | 857 | 720 | 640 | 671 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 901 | 1,058 | 993 | 949 | 995 |
| Net Goodwill | |||||
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 1,956 | 2,902 | 2,749 | 2,720 | 2,733 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 408 | 525 | 389 | 410 | 468 |
| Long Term Debt | |||||
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 625 | 1,036 | 903 | 967 | 958 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Other Equity | |||||
| Total Equity | 1,331 | 1,866 | 1,846 | 1,753 | 1,775 |
| Total Liabilities & Shareholders' Equity | 1,956 | 2,902 | 2,749 | 2,720 | 2,733 |
| Total Common Shares Outstanding |